ONCOSIGNATURE
Live / Allowed — Notice of allowance issued (as of 31 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 03 Aug 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98115652
- Mark type
- Stylized text
- Filed
- 03 Aug 2023
- Published for opposition
- 07 May 2024
- Attorney of record
- SARA M. BAUER
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medical preparations for the prediction of drug treatment efficacy; pharmaceutical and medical preparations for prognosis related to cancer; diagnostic kits consisting primarily of monoclonal antibodies for use in disease testing, specifically in oncology and premalignant disorders and benign tumors; reagents for medical use, namely, for medical diagnosis, drug-tailored efficacy predication and analysis; clinical medical reagents; diagnostic preparations for medical and veterinary purposes; diagnostic test materials for medical use in the field of oncology in the form of a clinical biomarker signature assay on biopsy or other patient sample material for measuring biomarkers reflective of disease-driving processes that the drug inhibits or does not inhibit to predict treatment efficacy within oncology; diagnostic preparations for medical use; diagnostic biomarker reagents for medical purposes; companion diagnostic biomarker reagents for medical purposes
- Class 044 — Medical, beauty and agricultural services: Medical services; medical testing for diagnosis or treatment purposes; medical diagnostic testing, monitoring, and reporting services; providing medical information, medical consultancy and medical advisory services; individual medical counseling services provided to patients; providing a website featuring medical information in the fields of oncology and precision medicine; providing medical information to medical professionals in the form of reports in the fields of oncology and precision medicine
Owner
- Acrivon Therapeutics, Inc., Watertown, MA, US
- Acrivon Therapeutics, Inc., Watertown, MA, US
Prior registrations
Prosecution history
- 31 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 28 Mar 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 19 Mar 2025 — TTAB RELEASE CASE TO TRADEMARKS
- 19 Mar 2025 — OPPOSITION TERMINATED NO. 999999
- 19 Mar 2025 — OPPOSITION DISMISSED NO. 999999
- 03 Nov 2024 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 01 Nov 2024 — OPPOSITION INSTITUTED NO. 999999
- 05 Jun 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 07 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 May 2024 — PUBLISHED FOR OPPOSITION
- 17 Apr 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 04 Apr 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Apr 2024 — ASSIGNED TO EXAMINER
- 26 Oct 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 26 Oct 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED